Reperio key facts
as of Oct 2026- Developer of an at-home health assessment platform designed for preventive care.
- Reperio is valued at approximately $60.0M as of Oct 2026 (last reported valuation).
- It has raised $32.0M; the latest was Seed Round ($14.0M) in May 2025.
- Notable investors include Liquid 2 Ventures, Portland Seed Fund, G Ventures (VC), Caduceus Capital Partners, Rogue Venture Partners.
- Status: Privately Held (backing).
Reperio's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch Reperio: the Monday email on marks, rounds and moves
Reperio funding rounds
No funding rounds for Reperio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Reperio valuation
Reperio's last reported valuation was $60 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Reperio investors
5 investors are on record for Reperio, including Liquid 2 Ventures, Portland Seed Fund, G Ventures (VC) and Caduceus Capital Partners.
About Reperio
Developer of an at-home health assessment platform designed for preventive care. The company's platform collects multiple health metrics in real-time, including blood pressure, resting heart rate, body mass index, relative fat mass, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and glucose levels, enabling individuals to monitor their health conveniently while ensuring accessibility to essential health information with AI-assisted virtual visit with a licensed medical professional.
- Sector
- Healthcare
- HQ
- Portland, OR, United States
- Founded
- 2020
- Employees
- 25
- Website
- reperiohealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.